EcoR1 Capital Reports Ownership Change in First Tracks Bio
Ticker: TRAX · Form: 4 · Filed: Apr 22, 2026 · CIK: 0002091349
Sentiment: neutral
Topics: insider-ownership, ownership-change
TL;DR
EcoR1 Capital changed its First Tracks Bio holdings on 4/20.
AI Summary
On April 20, 2026, EcoR1 Capital, LLC reported a change in beneficial ownership of securities for First Tracks Biotherapeutics, Inc. The filing, dated April 22, 2026, details transactions related to the ownership of First Tracks Biotherapeutics, Inc. securities.
Why It Matters
This filing indicates a shift in the holdings of a significant investor, EcoR1 Capital, in First Tracks Biotherapeutics, Inc., which could signal changes in the company's investor landscape.
Risk Assessment
Risk Level: low — Form 4 filings typically report routine changes in beneficial ownership and do not inherently indicate significant risk.
Key Players & Entities
- EcoR1 Capital, LLC (company) — Reporting Entity
- First Tracks Biotherapeutics, Inc. (company) — Issuer
- 0000935836-26-000208 (filing_id) — SEC Accession Number
- 2026-04-22 (date) — Filing Date
- 2026-04-20 (date) — Period of Report
FAQ
Who is the reporting entity in this filing?
The reporting entity is EcoR1 Capital, LLC.
What is the name of the issuer?
The issuer is First Tracks Biotherapeutics, Inc.
What is the SEC accession number for this filing?
The SEC accession number is 0000935836-26-000208.
On what date was this Form 4 filed?
This Form 4 was filed on April 22, 2026.
What period does this report cover?
This report covers the period ending April 20, 2026.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 22, 2026 regarding First Tracks Biotherapeutics, Inc. (TRAX). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.